Propranolol Competitive Antibody Pair

AccuSift
PPL
SKU Name Unit Price Delivery QTY
SR552 Propranolol monoclonal antibody 1mg $750 10days
TC552 Propranolol BSA antigen 1mg $300 10days
AccuSift provides high-performance propranolol competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.

Propranolol is a β‑adrenergic receptor blocker prescription drug. It non-selectively and competitively inhibits adrenaline β‑receptors, blocking β1 and β2 receptor activity, thereby reducing myocardial contractility and oxygen consumption. It also suppresses adrenergic nerve excitation and renin release, exerting antiarrhythmic and antihypertensive effects.
Propranolol is indicated for hypertension, exertional angina, supraventricular and ventricular tachyarrhythmias, reducing outflow tract pressure gradients and alleviating symptoms such as angina, palpitations, and syncope in hypertrophic cardiomyopathy. It is also used for combined preoperative management of pheochromocytoma, tachycardia associated with hyperthyroidism, thyroid storm, and secondary prevention of myocardial infarction.
Performance Characteristics:

  • Sensitivity: ELISA IC50: 2 ppb

  • Source: Mouse Monoclonal Antibody

  • Purity: ≥ 90%

  • Recommended Pairing: (Coating) / (Labeling)

  • Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.


Operation

References